(Q42277426)
Statements
Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation (English)
Tri-Hung Nguyen
Devi Ngo
Glenn A Edwards
23 January 2013
scientific article published on 23 January 2013
No description defined